Authors: SENEKOWITSCHSCHMIDTKE R MATZEN K TRUCKENBRODT R MATTES J HEISS P SCHWAIGER M

Citation: R. Senekowitschschmidtke et al., TUMOR-CELL SPHEROIDS AS A MODEL FOR EVALUATION OF METABOLIC CHANGES AFTER IRRADIATION, The Journal of nuclear medicine, 39(10), 1998, pp. 1762-1768

Authors: SENEKOWITSCHSCHMIDTKE R MATZEN K TRUCKENBRODT R MATTES J HEISS P

Citation: R. Senekowitschschmidtke et al., TUMOR-CELL SPHEROIDS - A MODEL FOR INTERPRETATION OF PET-STUDIES MONITORING THERAPY RESPONSE, European journal of cell biology, 74, 1997, pp. 147-147

Authors: SENEKOWITSCHSCHMIDTKE R STEINER K HAUNSCHILD J MOLLENSTADT S TRUCKENBRODT R

Citation: R. Senekowitschschmidtke et al., IN-VIVO EVALUATION OF EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR DENSITY ON HUMAN TUMOR XENOGRAFTS USING RADIOLABELED EGF AND ANTI-(EGF RECEPTOR) MAB-425, Cancer immunology and immunotherapy, 42(2), 1996, pp. 108-114

Authors: HAMACHER K HERZ M TRUCKENBRODT R STOCKLIN G SCHWAIGER M SENEKOWITSCHSCHMIDTKE R

Citation: K. Hamacher et al., 4-[F-18]FLUOROPROLINE - A POTENTIAL TRACER FOR COLLAGEN-SYNTHESIS - RADIOSYNTHESIS AND BIOLOGICAL EVALUATION, The Journal of nuclear medicine, 37(5), 1996, pp. 154-154

Authors: MATTES J MATZEN K TRUCKENBRODT R SENEKOWITSCH R SCHWAIGER M

Citation: J. Mattes et al., TUMOR-CELL SPHEROIDS - A 3-DIMENSIONAL MODEL FOR STUDIES ON PROLIFERATION AND CELL VIABILITY AFTER RADIOTHERAPY IN RELATIONSHIP TO FDG AND THYMIDINE UPTAKE, The Journal of nuclear medicine, 35(5), 1994, pp. 160000065-160000066

Authors: SENEKOWITSCH R GUNSENHEIMER B NUSSBAUMER J TRUCKENBRODT R FARO HP MOLLENSTADT S PABST HW

Citation: R. Senekowitsch et al., EVALUATION OF EGF-RECEPTORS AND THEIR BLOCKAGE ON HUMAN TUMOR-TISSUE BY MAB 425 AND ITS FRAGMENTS, The Journal of nuclear medicine, 34(5), 1993, pp. 219-219